Literature DB >> 19424588

MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation.

Li Yin1, Surender Kharbanda, Donald Kufe.   

Abstract

Tumor cells survive under conditions of nutrient deprivation by mechanisms that are not fully understood. The MUC1 oncoprotein is aberrantly overexpressed by most human carcinomas and blocks oxidative stress-induced death. The present studies show that MUC1 inhibits the induction of necrosis in response to the deprivation of glucose. MUC1 suppressed glucose deprivation-induced increases in reactive oxygen species (ROS) and thereby depletion of ATP and cell death. Cells respond to oxidative stress and energy depletion with the induction of autophagy. Our results demonstrate that MUC1 blocks depletion of ATP and sustains growth of glucose-deprived cells by a mechanism sensitive to the autophagy inhibitor, 3-methyladenine. Silencing expression of ATG7, a protein essential for the formation of autophagic vacuoles, also attenuated the MUC1-sustained increases in ATP and growth in response to glucose deprivation. Moreover, we found that MUC1 stimulates AMPK activation and thereby promotes lysosomal turnover of LC3-II, a marker of starvation-induced autophagic activity. These results indicate that MUC1 suppresses glucose deprivation-induced increases in ROS and thereby promotes ATP production and survival. The findings also indicate that the overexpression of MUC1 as found in human cancers could provide a survival advantage in microenvironments with low glucose levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424588      PMCID: PMC3027209          DOI: 10.3892/ijo_00000300

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  64 in total

Review 1.  Autophagy as a regulated pathway of cellular degradation.

Authors:  D J Klionsky; S D Emr
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

2.  The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin.

Authors:  Y Li; H Kuwahara; J Ren; G Wen; D Kufe
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

3.  Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells.

Authors:  T N Seagroves; H E Ryan; H Lu; B G Wouters; M Knapp; P Thibault; K Laderoute; R S Johnson
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 4.  Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid.

Authors:  J R Griffiths; D J McIntyre; F A Howe; M Stubbs
Journal:  Novartis Found Symp       Date:  2001

5.  The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.

Authors:  Y Li; J Ren; W Yu; Q Li; H Kuwahara; L Yin; K L Carraway; D Kufe
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

6.  Antagonistic controls of autophagy and glycogen accumulation by Snf1p, the yeast homolog of AMP-activated protein kinase, and the cyclin-dependent kinase Pho85p.

Authors:  Z Wang; W A Wilson; M A Fujino; P J Roach
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

7.  BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore.

Authors:  C Vande Velde; J Cizeau; D Dubik; J Alimonti; T Brown; S Israels; R Hakem; A H Greenberg
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells.

Authors:  K Saeki; A Yuo; E Okuma; Y Yazaki; S A Susin; G Kroemer; F Takaku
Journal:  Cell Death Differ       Date:  2000-12       Impact factor: 15.828

9.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma.

Authors:  Ming Gao; Pei Yen Yeh; Yen-Shen Lu; Chih-Hung Hsu; Kuen-Feng Chen; Wei-Chung Lee; Wen-Chi Feng; Ching-Shih Chen; Min-Liang Kuo; Ann-Lii Cheng
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

View more
  37 in total

Review 1.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

2.  MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells.

Authors:  Li Yin; Zekui Wu; David Avigan; Jacalyn Rosenblatt; Richard Stone; Surender Kharbanda; Donald Kufe
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

3.  MUC1 oncoprotein is a druggable target in human prostate cancer cells.

Authors:  Maya Datt Joshi; Rehan Ahmad; Li Yin; Deepak Raina; Hasan Rajabi; Glenn Bubley; Surender Kharbanda; Donald Kufe
Journal:  Mol Cancer Ther       Date:  2009-11-03       Impact factor: 6.261

4.  Survival of human multiple myeloma cells is dependent on MUC1 C-terminal transmembrane subunit oncoprotein function.

Authors:  Li Yin; Rehan Ahmad; Michio Kosugi; Turner Kufe; Baldev Vasir; David Avigan; Surender Kharbanda; Donald Kufe
Journal:  Mol Pharmacol       Date:  2010-05-05       Impact factor: 4.436

Review 5.  MUC1: a novel metabolic master regulator.

Authors:  Kamiya Mehla; Pankaj K Singh
Journal:  Biochim Biophys Acta       Date:  2014-01-11

6.  Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors.

Authors:  Yongchun Zhou; Hasan Rajabi; Donald Kufe
Journal:  Mol Pharmacol       Date:  2011-02-23       Impact factor: 4.436

7.  Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells.

Authors:  Deepak Raina; Rehan Ahmad; Hasan Rajabi; Govind Panchamoorthy; Surender Kharbanda; Donald Kufe
Journal:  Int J Oncol       Date:  2011-12-20       Impact factor: 5.650

Review 8.  Autophagy and cancer metabolism.

Authors:  Juliet Goldsmith; Beth Levine; Jayanta Debnath
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

9.  MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells.

Authors:  Suiyang Liu; Li Yin; Dina Stroopinsky; Hasan Rajabi; Alexandre Puissant; Kimberly Stegmaier; David Avigan; Surender Kharbanda; Donald Kufe; Richard Stone
Journal:  Blood       Date:  2013-11-26       Impact factor: 22.113

Review 10.  Mucins in cancer: function, prognosis and therapy.

Authors:  Donald W Kufe
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.